RIVM and EFSA optimise new calculation model for mixture risk assessment Plant protection products (PPPs) are products used in agriculture to protect crops against, for example, fungi, insects and weeds.
Participation rates in cancer population screening programmes continue to decline The number of participants in the population screening programmes for breast cancer, cervical cancer and colorectal cancer continues to decline. This decline has been going on for years, reaching its lowest point in 2020.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
GPs feel more personalised care for chronically ill patients was useful during coronavirus pandemic During the coronavirus pandemic, GPs had to take over some of the tasks of hospitals and mental healthcare providers.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
Post-COVID less common after Omicron infection After a SARS-CoV-2 infection involving Omicron, 1 in 10 people still have symptoms three months later. This is almost 2 times lower than after an infection involving the Delta variant. This is evident from new results of the LongCOVID study at RIVM. There is variation in the frequency of specific post-COVID symptoms after an infection with the Omicron or Delta variant.
International research confirms: lockdowns have negative impact on many young people Lockdowns have a negative impact on the physical and mental health of many young people. They get less exercise and experience more feelings of depression, loneliness and insecurity.
Quality of protective equipment insufficient during COVID-19 crisis The personal protective equipment (PPE) purchased at the national level during the COVID-19 crisis for use in the healthcare sector only partly met the required standards of quality.
Nearly a quarter-million positive COVID-19 tests last week Last week*, 242,961 positive COVID-19 tests were reported to RIVM**. That is an increase of 21% compared to the week before that.
200 thousand people tested positive in one week 201,536 positive COVID-19 tests were reported to RIVM last week. That is an increase of 77% compared to the previous week. Such high numbers of reported infections within just one week have never been seen before in the Netherlands.